Cytura Therapeutics BV

Cytura Therapeutics is an early stage pharmaceutical company, based at the Pivot Park Life Science Campus in Oss, the Netherlands.

Cytura Therapeutics BV was founded by entrepreneur Ad van Gorp and collaborates in close conjunction with the Amsterdam UMC and the Centre for Drug Design and Discovery (CD3) of the KU Leuven in developing a new revolutionary class of disruptive innovative drugs, targeting genomic instability in cancer.